Lawmakers consider restrictions to needle exchange programs
Maine lawmakers are considering a new bill that would limit the number of syringes given for each one returned at needle ...
pharmaphorum4d
FDA declines to approve needle-free epinephrine from ARS
Shares in ARS Pharmaceuticals were in freefall in pre ... aiming to become the first needle-free epinephrine product to treat severe allergic reactions. The nasal spray, dubbed neffy, has been ...
Pharm Exec12d
FDA Approves ARS Pharmaceuticals’ neffy for Type 1 Allergic Reactions in Pediatric Patients
3 According to ARS, around 40% of patients hold back on treatment and around 56% of caregivers are hesitant to treat children with needle-based auto-injectors. 1 “The availability of a needle-free ...
Med Device Online8y
Daikyo Crystal Zenith ® Insert Needle Syringe Systems
The Daikyo Crystal Zenith ® Insert Needle Syringe System minimizes potential contamination issues usually associated with glass vials. Daikyo Crystal Zenith ® Insert Needle Syringes maintain the ...
fbcnews26d
Experts push for Needle-Syringe Program
The Health Ministry is being urged to introduce needle-syringe programs to help curb the rising number of HIV cases in Fiji. According to the Ministry, sharing needles among drug users is fueling the ...
BioSpace1mon
ARS Pharmaceuticals Launches neffyinSchools Program Providing Free Life-Saving Needle-Free Epinephrine For Emergency Use to Eligible K-12 Schools
and CEO of ARS Pharma. “neffy is a groundbreaking device with a simple, needle-free design that we believe will make schools safer and better prepared to address anaphylaxis. While anaphylaxis can ...
Nasdaq12d
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg, First Needle-Free Epinephrine Treatment for Children Ages 4 and Up
neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...